Drug dis

Drug Repurposing: Challenges and Opportunities

  • Chair(s):

    Flora Musuamba,
    Co-Chair Modelling and Simulation Working Party, Federal Agency for Medicines and Health Products, Brussels, Belgium

    Oscar Della Pasqua,
    Chair Clinical Pharmacology & Therapeutics, University College London, London, United Kingdom

  • Session description:

    Drug repurposing and translational pharmacology: Lessons learned from COVID-19
    Oscar Della Pasqua
    Chair Clinical Pharmacology & Therapeutics, University College London, London, United Kingdom

    Drug repurposing in neurological diseases
    Dr Robert Pitceathly
    Honorary Consultant at The National Hospital for Neurology and Neurosurgery, UCL Queen Square Institute of Neurology, London, United Kingdom

    Oral communication speaker - to be confirmed in 2022.

    Barriers to bring repurposed medicines to paediatric patients
    Dr Giuseppe Pontrelli
    Clinical Trial Unit, University Department of Paediatrics, Bambino Gesù Children's Hospital,
    Rome, Italy

    Drug repurposing: regulatory experience and expectations
    Dr Flora Musuamba
    Federal Agency for Medicines and Health Products, Brussels, Belgium

  • 00

    days

  • 00

    hours

  • 00

    minutes

  • 00

    seconds

Date

06 Jul 2023

Time

9:45 am - 12:10 pm

Speakers

Leave A Comment